EPISODE · Dec 9, 2021 · 38 MIN
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
from Real Vision: Finance & Investing · host Real Vision Podcast Network
DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstrating promising results of neutralizing the virus. The October JOLTS numbers also were released, showing that 4.2 million Americans quit their jobs, a decrease from the previous month, and openings increased to slightly over 11 million. 42 Macro founder and CEO Darius Dale analyzes the labor market’s recovery, COVID’s continuing impact on markets, the implications of the U.S. House passing legislation on increasing the debt ceiling limit, and more. Interviewed by Ash Bennington. Want to submit questions? Drop them right here on the Exchange: https://rvtv.io/3dAjdo6 Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstrating promising results of neutralizing the virus. The October JOLTS numbers also were released, showing that 4.2 million Americans quit their jobs, a decrease from the previous month, and openings increased to slightly over 11 million. 42 Macro founder and CEO Darius Dale analyzes the labor market’s recovery, COVID’s continuing impact on markets, the implications of the U.S. House passing legislation on increasing the debt ceiling limit, and more. Interviewed by Ash Bennington. Want to submit questions? Drop them right here on the Exchange: https://rvtv.io/3dAjdo6 Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m